12 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
and stability testing, process and packaging development and improvement, process validation, process scale-up, formulation development, delivery system … , formulation, mean of delivery or dosage, use, or methods of use or packaging of such Licensed Compound or Licensed Product, any discovery or Development
20-F
2021 FY
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
is subject to comprehensive government regulation and supervision encompassing the approval, registration, manufacturing, packaging, licensing … , if the FDA, the NMPA or foreign regulatory authorities approve our product candidates, the manufacturing processes, labeling, packaging
424B4
CNTB
Connect Biopharma Holdings Ltd
19 Mar 21
Prospectus supplement with pricing info
4:49pm
, the NMPA or foreign regulatory authorities approve our product candidates, the manufacturing processes, labeling, packaging, distribution, adverse … to comprehensive government regulation and supervision encompassing the approval, registration, manufacturing, packaging, licensing and marketing of new
F-1/A
5grz8iqsa t8gz8
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
e7dy4mb1j57qx7 pr
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
EX-10.5
q1aztv5nb rpsn
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
81rs10gbos
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
jypssx 47
26 Jan 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.5
38qzczpa
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
uvdxr7z
17 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next